Medtronic Names Michael Marinaro President, Raises His Base Pay To $1,000,000

The 8-K says Marinaro adds Greater China oversight and still reports to Geoff Martha, who stays chairman and CEO.

Share
Medtronic Names Michael Marinaro President, Raises His Base Pay To $1,000,000

Medtronic's board approved Michael Marinaro as President, Medtronic, effective October 14, 2026, according to an 8-K filed Monday. Marinaro, previously an executive vice president, now also oversees Greater China, and his base salary rises to $1,000,000 for all of fiscal year 2027.

What the 8-K says about the role

The board acted on October 15. Marinaro was Executive Vice President and President of the Medical Surgical Portfolio, Americas, and Global Commercial Operations. He keeps those duties and adds oversight of Greater China.

Alex Gu, Senior Vice President and President, Greater China, will keep managing that region locally. Marinaro continues to report to Geoffrey S. Martha, who remains Chairman of the Board and Chief Executive Officer.

The pay changes

The Compensation and Talent Committee raised Marinaro's base salary to $1,000,000 for all of fiscal year 2027. His target annual incentive stays at 100% of base salary.

The committee also approved supplemental fiscal 2027 long-term awards with an aggregate target value of about $3.25 million, all to be granted on November 2, 2026:

  • A performance share unit award with a target value of $1.625 million, vesting April 27, 2029 based on fiscal 2027 through fiscal 2029 performance.
  • A stock option award with a grant date value of $975,000, vesting in four equal annual installments beginning August 3, 2027, with a ten-year term.
  • A restricted stock unit award worth $650,000, vesting in full on August 3, 2029.

Same filing: MiniMed separation and annual meeting

The 8-K also furnishes a press release saying the MiniMed separation is complete. Medtronic exchanged its remaining 252,813,348 MiniMed shares in an exchange offer the company said was 5.4x subscribed. Martha said the split lets Medtronic put its full weight behind its Cardiovascular, Neuroscience and Surgical portfolios.

Shareholders also voted at the October 15 annual meeting. Each of twelve directors was elected, and the advisory vote on executive pay passed with 936,336,164 votes for and 62,496,763 against.

Medtronic shares closed at $92.77 in Monday trading, down 2.09% from the prior session, before the filing was accepted at 4:23 p.m. ET.

The supplemental awards are scheduled to be granted on November 2, 2026.

Sources

More on Medtronic

All Medtronic (MDT) coverage →